INS and Insulin resistance: This, although striking, is to be expected, taking into account the well-reported glucose-lowering effect of metformin in T2DM European adult populations [8,24,26,32,33] and the improvement of insulin status in patients with hyperinsulinemia or insulin resistance [34,35].